BWX Technologies IncRaised full-year adjusted EPS guidance and beat Q2 estimates, with strong backlog growth.

BWX Technologies raised its full-year adjusted EPS guidance to $4.75 at the midpoint, a 1.6% increase, following second-quarter results that beat analyst estimates. Revenue reached $901.6 million, up 18% year-on-year and roughly in line with the $904 million consensus, while adjusted EPS of $1.07 exceeded the $1.04 estimate. Adjusted EBITDA came in at $155.5 million, above the $149.5 million forecast, and the company guided full-year EBITDA to $667 million, topping the $652.9 million analyst expectation. Management highlighted strong demand across government and commercial nuclear operations, a 39.6% jump in backlog to $8.40 billion, and plans to redeploy capital from the medical business sale into core markets.
BWX Technologies IncRaised full-year adjusted EPS guidance and beat Q2 estimates, with strong backlog growth.